Prostate specific antigen in benign prostatic hyperplasia: Purification and characterization

Journal of Urology

Volumn 157, Issue 6, 1997, Pages 2166-2170

  Chen, Zuxiong ^a   Chen, Haibin ^a   Stamey, Thomas A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

prostate; prostate specific antigen; prostatic hypertrophy; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN DETECTION; ANTIGEN SPECIFICITY; ARTICLE; CASE REPORT; ENZYME ASSAY; ENZYME PURIFICATION; HUMAN; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE DISEASE; PROSTATE HYPERTROPHY; SEMINAL PLASMA;

EID: 0030990262     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64704-9     Document Type: Article

References (32)

1. Akiyama, K., Nakamura, T., Iwanaga, S. and Hara, M.: The chymotrypsin-like activity of human prostate-specific antigen, gamma-seminoprotein. FEBS Lett., 225: 168, 1987.
2. Christensson, A., Laurell, C.-B. and Lilja, H.: Enzymatic activity of the prostate-specific antigen and its reactions with extra-cellular serine proteinase inhibitors. Eur. J. Biochem., 194: 755, 1990.
3. Watt, K. W. K., Lee, P. J., M'Timkulu, T., Chan, W.-P. and Loor, R.: Human prostate-specific antigen: structural and functional similarity with serine proteases. Proc. Nat. Acad. Sci. 83: 3166, 1986.
4. Lundwall, A. and Lilja, H.: Molecular cloning of human prostate specific antigen cDNA. FEBS Lett., 214: 317, 1987.
5. Bélanger, A., van Halbeek, H., Graves, H. C., Grandbois, K., Stamey, T. A., Huang, L., Poppe, I. and Labrie, F.: Molecular mass and carbohydrate structure of prostate specific antigen: studies for establishment of an international PSA standard. Prostate, 27: 187, 1995.
6. Stenman, U. H., Leinonen, J., Alfthan, H., Rannikko, S., Tuhkanen, K. and Afthan, O.: A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res., 51: 222, 1991.
7. Armbruster, D. A.: Prostate-specific antigen: biochemistry, analytical methods, and clinical application. Clin. Chem., 39: 181, 1993.
8. Wang, M. C., Valenzuela, L. A., Murphy, G. P. and Chu, T. M.: Purification of a human prostate specific antigen. Invest. Urol., 17: 159, 1979.
9. Stamey, T. A., Yang, N., Hay, A. R., McNeal, J. E., Freiha, F. S. and Redwine, E.: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. New Engl. J. Med., 317: 909, 1987.
10. Oesterling, J. E.: Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J. Urol., 145: 907, 1991.
11. Lilja, H., Christensson, A., Dahlén, U., Matikainen, M.-T., Nilsson, O., Pettersson, K. and Lövgren, T.: Prostate-specific antigen in human serum occurs predominantly in complex with α1-antichymotrypsin. Clin. Chem., 37: 1618, 1991.
12. Christensson, A., Björk, T., Nilsson, O., Dahlén, U., Matikainen, M.-T., Cockett, A. T. K., Abrahamsson, P.-A. and Lilja, H.: Serum prostate specific antigen complexed to α1-antichymotrypsin as an indicator of prostate cancer. J. Urol., 150: 100, 1993.
13. Catalona, W. J., Smith, D. S., Wolfert, R. L., Wang, T. J., Rittenhouse, H. G., Ratliff, T. L. and Nadler, R. B.: Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. J.A.M.A., 274: 1214, 1995.
14. Prestigiacomo, A. F., Lilja, H., Pettersson, K., Wolfert, R. L. and Stamey, T. A.: A comparison of the free fraction of serum prostate specific antigen in men with benign and cancerous prostates: the best case scenario. J. Urol., 156: 350, 1996.
15. Stamey, T. A., Chen, Z. and Prestigiacomo, A.: Serum prostate specific antigen binding α1-antichymotrypsin: influence of cancer volume, location and therapeutic selection of resistant clones. J. Urol., 152: 1510, 1994.
16. Sensabaugh, G. F. and Blake, E. T.: Seminal plasma protein p30: simplified purification and evidence for identity with prostate specific antigen. J. Urol., 144: 1523, 1990.
17. Laemmli, U. K.: Cleavage of structure proteins during the assembly of the head of bacteriophage T4. Nature, 227: 680, 1970.
18. Schägger, H. and von Jagow, G.: Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem., 166: 368, 1987.
19. Turner, B. M.: The use of alkaline-phosphotase-conjugated second antibody for the visualization of electrophoretically separated proteins recognized by monoclonal antibodies. J. Immunol. Methods, 63: 1, 1983.
20. Svendsen, L., Blombäck, B., Blombäck, M. and Olsson, P. I.: Synthetic chromogenic substrates for determination of trypsin, thrombin and thrombin-like enzymes. Thromb. Res., 1: 267, 1972.
21. Matsudaira, P.: Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J. Biol. Chem., 262: 10035, 1987.
22. Catalona, W. J., Richie, J. P., Ahmann, F. R., Hudson, M. A., Scardino, P. T., Flanigan, R. C., deKernion, J. B., Ratliff, T. L., Kavoussi, L. R., Dalkin, B. L., Waters, W. B., MacFarlane, M. T. and Southwick, P. C.: Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J. Urol., 151: 1283, 1994.
23. Carter, H. B. and Pearson, J. D.: PSA velocity for the diagnosis of early prostate cancer. A new concept. Urol. Clin. N. Amer., 20: 665, 1993.
24. Benson, M. C., Whang, I. S., Olsson, C. A., McMahon, D. J. and Cooner, W. H.: The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J. Urol., 147: 817, 1992.
25. Collins, G. N., Lee, R. J., McKelvie, G. B., Rogers, A. C. and Hehir, M.: Relationship between prostate specific antigen, prostate volume and age in the benign prostate. Brit. J. Urol., 71: 445, 1993.
26. Oesterling, J. E., Jacobsen, S. J., Chute, C. G., Guess, H. A., Girman, C. J., Panser, L. A. and Lieber, M. M.: Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. J.A.M.A., 270: 860, 1993.
27. Stamey, T. A., Barnhill, S. D., Zhang, Z., Madyastha, K. R., Prestigiacomo, A. F., Jones, K. and Chan, D.: Effectiveness of ProstAsure in detecting prostate cancer (PCa) and benign prostatic hyperplasia (BPH) in men age 50 and older. J. Urol., part 2, 155: 436A, abstract 504, 1996.
28. Prestigiacomo, A. F. and Stamey, T. A.: Can free and total prostate specific antigen and prostatic volume distinguish between men with negative and positive systemic ultrasound guided prostate biopsies? J. Urol., 157: 189, 1997.
29. Zhang, W. M., Leinonen, J., Kalkkinen, N., Dowell, B. and Stenman, U.-H.: Purification and characterization of different molecular forms of prostate-specific antigen in human seminal fluid. Clin. Chem., 41: 1567, 1995.
30. Leinonen, J., Zhang, W.-M. and Stenman, U.-H.: Complex formation between PSA isoenzymes and protease inhibitors. J. Urol., 155: 1099, 1996.
31. Chen, Z., Kamato, K., Prestigiacomo, A. and Stamey, T. A.: Addition of purified prostate specific antigen to serum from female subjects: studies on the relative inhibition by α2-macroglobulin and α1-antichymotrypsin. J. Urol., 156: 1357, 1996.
32. Hammerer, P. G., McNeal, J. E. and Stamey, T. A.: Correlation between serum prostate specific antigen levels and the volume of the individual glandular zones of the human prostate. J. Urol., 153: 111, 1995.